Basak Ajoy, Goswami Mukunda, Rajkumar Abishankari, Mitra Tapobrata, Majumdar Swapan, O'Reilly Paul, Bdour Hussam M, Trudeau Vance L, Basak Amit
Interdisciplinary School of Health Sciences Unit, Faculty of Health Science, U Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada; Chronic Disease Program, Ottawa Hospital Research Institute, U Ottawa, Canada.
Interdisciplinary School of Health Sciences Unit, Faculty of Health Science, U Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada; Centre for Advanced Research in Environmental Genomics, Department of Biology, U Ottawa, Canada.
Bioorg Med Chem Lett. 2015;25(10):2225-37. doi: 10.1016/j.bmcl.2015.03.029. Epub 2015 Mar 23.
The proprotein convertases PCSK8 and PCSK4 are, respectively, the 8th and 4th members of Ca(+2)-dependent serine endoprotease of Proprotein Convertase Subtilisin Kexin (PCSK) super family structurally related to the bacterial subtilisin and yeast kexin. The membrane bound PCSK8 (also called SKI-1 or S1P) is implicated in sterol regulation and lipid synthesis via its role in the maturation of human (h) SREBP-2. It also plays role in cartilage formation, bone mineralization, as well as viral pathogenesis. On the other hand, PCSK4 has been linked to mammalian fertilization and placenta growth. Owing to these findings, interest has grown to develop specific inhibitors against these enzymes for potential biochemical and therapeutic applications. In this study we developed two types of small molecule inhibitors of PCSK8 and PCSK4 and demonstrated their anti-proteolytic activities in vitro cell-free and in vitro cell culture systems. These are isocoumarinyl methyl sulfone derivatives and enediyne amino acid containing peptides. Our in vitro data suggested that one of the 7 sulfone derivatives (methyl phenyl sulfone) inhibited PCSK8 with inhibition constant Ki ∼255μM. It also blocked PCSK8-mediated processing of hSREBP-2 in HepG2 cell in a concentration-dependent manner. However all 7 iso-coumarinyl methyl sulfones inhibited htrypsin with IC50 ranging from 2 to 165μM. In contrast, all our designed enediynyl peptides inhibited PCSK8 and PCSK4 activity with Ki and IC50 in low μM or high nM ranges. All compounds exhibited competitive inhibition as indicated by their enzyme kinetic plots and observed dependence of IC50 value on substrate concentration. Our study confirmed that incorporation at the substrate cleavage site of 'Enediyne amino acid' generates potent inhibitors of PCSK8 and PCSK4. This represents a novel approach for future development of inhibitors of PCSK or other enzymes.
前蛋白转化酶PCSK8和PCSK4分别是前蛋白转化酶枯草杆菌蛋白酶/kexin(PCSK)超家族中依赖Ca(+2)的丝氨酸内切蛋白酶的第8和第4个成员,在结构上与细菌枯草杆菌蛋白酶和酵母kexin相关。膜结合的PCSK8(也称为SKI-1或S1P)通过其在人(h)SREBP-2成熟过程中的作用参与固醇调节和脂质合成。它还在软骨形成、骨矿化以及病毒发病机制中发挥作用。另一方面,PCSK4与哺乳动物受精和胎盘生长有关。基于这些发现,人们对开发针对这些酶的特异性抑制剂以用于潜在的生化和治疗应用的兴趣日益浓厚。在本研究中,我们开发了两种类型的PCSK8和PCSK4小分子抑制剂,并在体外无细胞和体外细胞培养系统中证明了它们的抗蛋白水解活性。这些是异香豆素基甲基砜衍生物和含烯二炔氨基酸的肽。我们的体外数据表明,7种砜衍生物之一(甲基苯基砜)以抑制常数Ki约为255μM抑制PCSK8。它还以浓度依赖的方式阻断HepG2细胞中PCSK8介导的hSREBP-2加工。然而,所有7种异香豆素基甲基砜均以IC50范围为2至165μM抑制h胰蛋白酶。相比之下,我们设计的所有烯二炔肽均以低μM或高nM范围内的Ki和IC50抑制PCSK8和PCSK4活性。所有化合物均表现出竞争性抑制,这由它们的酶动力学图以及观察到的IC50值对底物浓度的依赖性表明。我们的研究证实,在“烯二炔氨基酸”的底物切割位点掺入可产生PCSK8和PCSK4的有效抑制剂。这代表了未来开发PCSK或其他酶抑制剂的一种新方法。